A Monongraph Series Devoted To The Understanding of Medicine, Mental Health, Mind , Man And Their Maxtrix
Abstract Cognitive Neuroscience is an interdisciplinary area of research that combines measurement of brain activity (mostly by means of neuroimaging) with a simultaneous performance of cognitive tasks by human subjects. These investigations have been successful in the task of connecting the sciences of the brain (Neurosciences) and the sciences of the mind (Cognitive Sciences). Advances […]
What The Cognitive Neurosciences Mean To Me Read More »
Abstract The paper reviews some ways that the social and psychic have been understood in psychoanalysis and argues that a model for understanding the relation between the psychic and the social must account both for the ways that we internalize oppressive norms as well as the ways we resist them. The author proposes that we
What Psychoanalysis, Culture And Society Mean To Me Read More »
What is the ideal combination of increased investment in biomedical research by sponsors with least conflict of interest in researchers? What should interested parties do to refurbish pharma’s image? Is a voluntary moratorium on pharma spending practically possible? How to resolve the basic schism between profit driven industry and welfare driven profession of medicine? How
Questions That This Monograph Raises Read More »
Private investment in biomedical research has increased over the last few decades. At most places it has been welcomed as the next best thing to technology itself. There are significant costs involved too. Major areas of conflict of interest especially applicable to biomedical research have arisen, as academia interacts with industry. Pharma image stinks because
Concluding Remarks Read More »
In this final section, we shall see what are the ground realities that both industry and academia-biomedicine have to acknowledge; what are the major propellants of the pharma industry; what is the difference between marketing a pharma and any other product; how tactics of the short term industry player, although attractive, are unsuited for the
What Propels The Pharma Industry? Read More »
In this section, we look at how the biological paradigm shift in psychiatry has been aided and abetted by industry for serving its own needs; which stymies other promising approaches; but which, nonetheless, can serve to advance biomedicine if checks and balances are in place. Go to: Industry, Biological Psychiatry And Non-pharmacological Advance The larger
Biological Psychiatry, Research And Industry Read More »
In this section we look into the difference between useful and marketable entities, how industry funds new and not traditional therapies and what impact this has on biomedical advance and patient care. Go to: Useful And Marketable Focus on the marketability rather than usefulness of products is an area of concern. There is an inevitable
Useful And Marketable, New And Traditional Read More »
Chapter V on Foundations and Task Forces discussed issues related to research obligations towards human research subjects. This chapter takes the discussion further and is concerned with the ethical obligations of investigators. The remedy suggested is looking into the contract process for clinical research and following Best Practices Guidelines and Good Publication Practice Guidelines. Go
Ethical Obligation Towards Research Subjects Read More »
This section will detail some important initiatives taken by journal editors in writing about industry influence on academia in particular and medicine in general. It will also look into the Revised Guidelines of the ICMJE vis-á-vis issues related to industry-sponsored research. Go to: Journals And Editors In the last chapter, we saw how conflict of
Concerned Journals, Editors And ICMJE Read More »
This chapter looks into how Foundations are influenced by Industry in the light of the case of the American Heart Foundation, Genentech and the drug Altepase. It also discusses important ramifications of the reports of two Task Forces of the AAMC, which discuss individual and institutional conflict of interest. Go to: American Heart Foundation And
Foundations And Task Forces Read More »